EMA Authorised: Winlevi (clascoterone) — Cassiopea S.p.A.

View source ↗

Summary

The European Medicines Agency has authorized Winlevi (clascoterone) by Cassiopea S.p.A. for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Winlevi (clascoterone)

Snippet

Status: Authorised. Therapeutic area: Acne Vulgaris. MAH: Cassiopea S.p.A.. Decision date: 17/10/2025